Skip to main content
AAN.com
Brief Communications
October 9, 2006

Clinical features associated with impulse control disorders in Parkinson disease

October 10, 2006 issue
67 (7) 1258-1261

Abstract

In patients with Parkinson disease (PD), impulse control disorders (ICDs) such as hypersexuality and pathologic gambling and shopping can be devastating complications of antiparkinsonian treatment. To improve their detection, we investigated clinical features associated with ICDs. Subjects were participants in a longitudinal study of PD. ICDs were associated with use of dopamine agonists and depressed mood, disinhibition, irritability, and appetite disturbance.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Grant JE, Levine L, Kim D, et al. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005;162:2184–2188.
2.
Avanzi M, Uber E, Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Neurol Sci 2004;25:98–101.
3.
Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62:1377–1381.
4.
Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003;61:422–423.
5.
Gschwandtner U, Aston J, Renaud S, et al. Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol 2001;24:170–172.
6.
Klos KJ, Bower JH, Josephs KA, et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005;11:381–386.
7.
Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
8.
Dell'Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review.Clin Pract Epidemol Ment Health 2005;1:21.
9.
Kurlan R. Disabling repetitive behaviors in Parkinson's disease. Mov Disord 2004;19:433–437.
10.
Bordet R, Ridray S, Carboni S, et al. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 1997;94:3363–3367.

Information & Authors

Information

Published In

Neurology®
Volume 67Number 7October 10, 2006
Pages: 1258-1261
PubMed: 17030761

Publication History

Published online: October 9, 2006
Published in print: October 10, 2006

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Gregory Pontone, MD
From the Departments of Psychiatry and Behavioral Sciences (G.P., S.S.B., L.M.) and Mental Health (J.R.W.), Bloomberg School of Public Health, Department of Neurology (L.M.), and Morris K. Udall Parkinson's Disease Research Center of Excellence at Johns Hopkins (J.R.W., S.S.B., L.M.), Johns Hopkins University School of Medicine, Baltimore, MD.
James R. Williams, MHS
From the Departments of Psychiatry and Behavioral Sciences (G.P., S.S.B., L.M.) and Mental Health (J.R.W.), Bloomberg School of Public Health, Department of Neurology (L.M.), and Morris K. Udall Parkinson's Disease Research Center of Excellence at Johns Hopkins (J.R.W., S.S.B., L.M.), Johns Hopkins University School of Medicine, Baltimore, MD.
Susan Spear Bassett, PhD
From the Departments of Psychiatry and Behavioral Sciences (G.P., S.S.B., L.M.) and Mental Health (J.R.W.), Bloomberg School of Public Health, Department of Neurology (L.M.), and Morris K. Udall Parkinson's Disease Research Center of Excellence at Johns Hopkins (J.R.W., S.S.B., L.M.), Johns Hopkins University School of Medicine, Baltimore, MD.
Laur Marsh, MD
From the Departments of Psychiatry and Behavioral Sciences (G.P., S.S.B., L.M.) and Mental Health (J.R.W.), Bloomberg School of Public Health, Department of Neurology (L.M.), and Morris K. Udall Parkinson's Disease Research Center of Excellence at Johns Hopkins (J.R.W., S.S.B., L.M.), Johns Hopkins University School of Medicine, Baltimore, MD.

Notes

Address correspondence and reprint requests to Dr. Laura Marsh, Johns Hopkins University School of Medicine, 600 N. Wolfe Street–Phipps 300, Baltimore, MD 21287; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease, Neurology Clinical Practice, 2, 4, (267-274), (2023)./doi/10.1212/CPJ.0b013e318278be9b
    Abstract
  2. Frequency and Characteristics of Psychosis in Parkinson’s Disease: A Systematic Review and Meta-Analysis, Journal of Parkinson's Disease, 12, 1, (85-94), (2022).https://doi.org/10.3233/JPD-212930
    Crossref
  3. undefined, 2022 29th National and 7th International Iranian Conference on Biomedical Engineering (ICBME), (129-134), (2022).https://doi.org/10.1109/ICBME57741.2022.10053026
    Crossref
  4. Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease, Cognition in Parkinson's Disease, (309-343), (2022).https://doi.org/10.1016/bs.pbr.2022.01.012
    Crossref
  5. Definition and Classification of Parkinsonian Drugs, NeuroPsychopharmacotherapy, (2823-2852), (2022).https://doi.org/10.1007/978-3-030-62059-2_213
    Crossref
  6. Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies, Frontiers in Psychiatry, 12, (2021).https://doi.org/10.3389/fpsyt.2021.635494
    Crossref
  7. Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management, Current Opinion in Neurology, 34, 4, (547-555), (2021).https://doi.org/10.1097/WCO.0000000000000955
    Crossref
  8. Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale, Journal of Clinical Neurology, 16, 2, (245), (2020).https://doi.org/10.3988/jcn.2020.16.2.245
    Crossref
  9. Impulse Control and Related Disorders in Parkinson's Disease: Special Issues and Implications, Psychiatric Annals, 50, 3, (107-112), (2020).https://doi.org/10.3928/00485713-20200211-01
    Crossref
  10. Altruistic Punishment and Impulsivity in Parkinson’s Disease: A Social Neuroscience Perspective, Frontiers in Behavioral Neuroscience, 14, (2020).https://doi.org/10.3389/fnbeh.2020.00102
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share